AI assistant
PFIZER INC — Director's Dealing 2022
Feb 26, 2022
29831_dirs_2022-02-25_6895d1b7-a130-46b2-8f8b-0f9f68b01afe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2022-02-23
Reporting Person: SUSMAN SALLY (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-23 | Common Stock | M | 76895.0000 | $27.3400 | Acquired | 166470.0000 | Direct |
| 2022-02-23 | Common Stock | F | 19110.0000 | $46.8700 | Disposed | 147360.0000 | Direct |
| 2022-02-23 | Common Stock | F | 38060.0000 | $51.2800 | Disposed | 109300.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-23 | Stock Appreciation Rights | $27.3400 | M | 76895.0000 | Disposed | 2022-02-23 | Common Stock (76895.0000) | Direct |
| 2022-02-24 | Stock Appreciation Rights | $45.9600 | A | 40151.0000 | Acquired | 2027-02-24 | Common Stock (40151.0000) | Direct |
| 2022-02-24 | Stock Appreciation Rights | $45.9600 | A | 35313.0000 | Acquired | 2029-02-24 | Common Stock (35313.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 746.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F5: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F6: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.